SCYNEXIS, Inc. (Nasdaq: SCYX) announced that the Company has entered into an Asset Purchase agreement with UK-based Cypralis Limited, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE